Home NDC 80674-210 Sesquient
Product NDC 80674-210
11-digit product format 806740210
Labeler code 80674
Product ID 80674-210_8fa2abc6-e2d1-4647-a090-ca2f83481f5f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name fosphenytoin sodium
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Sedor Pharmaceuticals, LLC
Application NDA210864
Marketing category NDA
Marketing start 2021-06-01
Marketing end 0000-00-00
Substance FOSPHENYTOIN SODIUM
Active strength 500 mg/10mL
Pharmacologic classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C8 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 2D6 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 80674-210-10 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 80674-210-10 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 80674-210-10 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 80674-210-10 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 80674-210-10 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 80674-210-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 80674-210-10 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 80674-210-10 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 80674-210-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 80674-210-10 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 80674-210-10 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 80674-210-10 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 80674-210-10 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 80674-210-10 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 80674-210-10 I Inactivated by FDA bd6a592717d7…303034d00443…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N210864-001 SESQUIENT FOSPHENYTOIN SODIUM EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 N210864-002 SESQUIENT FOSPHENYTOIN SODIUM EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N210864-001 7635773 2029-03-13 Drug product 2020-12-01 N210864-001 8410077 2029-03-13 Drug product 2020-12-01 N210864-001 9200088 2029-03-13 Drug product 2020-12-01 N210864-001 9750822 2029-03-13 Drug product 2020-12-01 N210864-001 9493582 2033-02-27 Drug product 2020-12-01 N210864-002 7635773 2029-03-13 Drug product 2020-12-01 N210864-002 8410077 2029-03-13 Drug product 2020-12-01 N210864-002 9200088 2029-03-13 Drug product 2020-12-01 N210864-002 9750822 2029-03-13 Drug product 2020-12-01 N210864-002 9493582 2033-02-27 Drug product 2020-12-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 74 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N210864-001 SESQUIENT EQ 100MG PHENYTOIN NA/2ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N210864-002 SESQUIENT EQ 500MG PHENYTOIN NA/10ML (EQ 50MG PHENYTOIN NA/ML) SOLUTION / INTRAVENOUS RLD 2020-11-05 782e0a99824c…
Observed Orange Book patent history# Patent history page 1 of 10 · 370 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N210864-001 7635773 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-001 8410077 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-001 9200088 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-001 9750822 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-001 9493582 2033-02-27 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-002 7635773 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-002 8410077 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-002 9200088 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-002 9750822 2029-03-13 Drug product 2020-12-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N210864-002 9493582 2033-02-27 Drug product 2020-12-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N210864-001 7635773 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-001 8410077 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-001 9200088 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-001 9750822 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-001 9493582 2033-02-27 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-002 7635773 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-002 8410077 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-002 9200088 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-002 9750822 2029-03-13 Drug product 2020-12-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N210864-002 9493582 2033-02-27 Drug product 2020-12-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-001 7635773 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-001 8410077 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-001 9200088 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-001 9750822 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-001 9493582 2033-02-27 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-002 7635773 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-002 8410077 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-002 9200088 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-002 9750822 2029-03-13 Drug product 2020-12-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N210864-002 9493582 2033-02-27 Drug product 2020-12-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N210864-001 7635773 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-001 8410077 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-001 9200088 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-001 9750822 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-001 9493582 2033-02-27 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-002 7635773 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-002 8410077 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-002 9200088 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-002 9750822 2029-03-13 Drug product 2020-12-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N210864-002 9493582 2033-02-27 Drug product 2020-12-01 6a471c1ec25d…
FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 80674-210-10 80674021010 10 VIAL, SINGLE-USE in 1 CARTON (80674-210-10) > 10 mL in 1 VIAL, SINGLE-USE (80674-210-01) 2021-06-01 0000-00-00 No No Current